...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Changes in mRNA levels of fibrinogen subunit polypeptides in rats defibrinogenated with batroxobin.
【24h】

Changes in mRNA levels of fibrinogen subunit polypeptides in rats defibrinogenated with batroxobin.

机译:巴曲酶原纤维化后大鼠纤维蛋白原亚基多肽mRNA水平的变化。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Batroxobin is a snake venom that is a thrombinlike enzyme used for clinical treatment. We analyzed hepatic mRNA levels for fibrinogen subunit polypeptides and prothrombin by reverse transcription-polymerase chain reaction as well as coagulation and fibrinolysis factors in plasma 1, 3, 5 and 24 hours after Batroxobin treatment (3 BU/100 g) in rats. The mRNA levels of alpha- and beta-chains of fibrinogen were significantly increased with decreases in plasma fibrinogen, alpha2-plasmin inhibitor, and plasminogen levels, while the mRNA levels for prothrombin remained unchanged. These results suggest that fibrinogen mRNA synthesis is regulated by plasma fibrinogen levels in Batroxobin-induced defibrinogenated rats.
机译:巴曲酶是一种蛇毒,是一种用于临床治疗的凝血酶样酶。我们通过巴曲酶治疗(3 BU / 100 g)后1、3、5和24小时,通过逆转录-聚合酶链反应以及血浆中的凝血和纤溶因子分析肝纤维蛋白原亚基多肽和凝血酶原的mRNA水平。随着血浆纤维蛋白原,α2-纤溶酶抑制剂和纤溶酶原水平的降低,纤维蛋白原的α-链和β-链的mRNA水平显着增加,而凝血酶原的mRNA水平保持不变。这些结果表明,在巴曲酶诱导的去纤维化大鼠中,血浆纤维蛋白原水平调节纤维蛋白原mRNA的合成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号